Itau Unibanco Holding S.A. Tricida, Inc. Transaction History

Itau Unibanco Holding S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$29.6 - $43.71 $21,904 - $32,345	-740 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$31.16 - $39.46 $28,012 - $35,474	-899 Reduced 54.85%	740 $29,000
Q4 2018 Feb 13, 2019	BUY	$23.57 - $32.33 $1,225 - $1,681	52 Added 3.28%	1,639 $38,000
Q3 2018 Nov 13, 2018	BUY	$22.5 - $39.35 $35,707 - $62,448	1,587 New	1,587 $48,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.